Erythroleukoplakia
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab in Treating Participants With Leukoplakia (NCT03603223) | Jonsson Comprehensive Cancer Center | 2019-05-03 |
Track Erythroleukoplakia automatically
Every clearance here is in the API, with alerts when new ones post.